Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingxiang Liao

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Cellular proteolytic systems in P450 degradation: evolutionary conservation from Saccharomyces cerevisiae to mammalian liverMaria Almira Correia, Mingxiang Liao
Chinese Medical Journal|April 5, 2002
Effect of trans-acting factor on rat glutathione S-transferase P1 gene transcription regulation in tumor cellsDongyuan Liu, Mingxiang Liao, Jin Zuo, et al.
IEEE Transactions on Neural Networks and Learning Systems|March 3, 2025
Hierarchical AttentionShift for Pointly Supervised Instance SegmentationMingxiang Liao, Fang Wan, Zonghao Guo, et al.
Current Drug Discovery Technologies|September 17, 2010
Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactionsChuang Lu, Mingxiang Liao, Lawrence Cohen, et al.
Molecular Pharmacology|March 25, 2006
Endoplasmic reticulum-associated degradation of cytochrome P450 CYP3A4 in Saccharomyces cerevisiae: further characterization of cellular participants and structural determinantsMingxiang Liao, Saadia Faouzi, Andrey Karyakin, et al.
The Journal of Biological Chemistry|November 26, 2010
Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome P450 3A extraction into the cytosolPoulomi Acharya, Mingxiang Liao, Juan C Engel, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 17, 2022
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced CancerMingxiang Liao, Jie Zhou, Kenton Wride, et al.
Molecular Pharmacology|February 11, 2005
Vacuolar degradation of rat liver CYP2B1 in Saccharomyces cerevisiae: further validation of the yeast model and structural implications for the degradation of mammalian endoplasmic reticulum P450 proteinsMingxiang Liao, Victor G Zgoda, Victor A Zgoda, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2022
The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic ModelsLiliane Robillard, Mingxiang Liao, Minh Nguyen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 22, 2007
CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profilePing Kang, Mingxiang Liao, Michael R Wester, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Cellular proteolytic systems in P450 degradation: evolutionary conservation from Saccharomyces cerevisiae to mammalian liverMaria Almira Correia, Mingxiang Liao
Chinese Medical Journal|April 5, 2002
Effect of trans-acting factor on rat glutathione S-transferase P1 gene transcription regulation in tumor cellsDongyuan Liu, Mingxiang Liao, Jin Zuo, et al.
IEEE Transactions on Neural Networks and Learning Systems|March 3, 2025
Hierarchical AttentionShift for Pointly Supervised Instance SegmentationMingxiang Liao, Fang Wan, Zonghao Guo, et al.
Current Drug Discovery Technologies|September 17, 2010
Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactionsChuang Lu, Mingxiang Liao, Lawrence Cohen, et al.
Molecular Pharmacology|March 25, 2006
Endoplasmic reticulum-associated degradation of cytochrome P450 CYP3A4 in Saccharomyces cerevisiae: further characterization of cellular participants and structural determinantsMingxiang Liao, Saadia Faouzi, Andrey Karyakin, et al.
The Journal of Biological Chemistry|November 26, 2010
Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome P450 3A extraction into the cytosolPoulomi Acharya, Mingxiang Liao, Juan C Engel, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 17, 2022
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced CancerMingxiang Liao, Jie Zhou, Kenton Wride, et al.
Molecular Pharmacology|February 11, 2005
Vacuolar degradation of rat liver CYP2B1 in Saccharomyces cerevisiae: further validation of the yeast model and structural implications for the degradation of mammalian endoplasmic reticulum P450 proteinsMingxiang Liao, Victor G Zgoda, Victor A Zgoda, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2022
The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic ModelsLiliane Robillard, Mingxiang Liao, Minh Nguyen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 22, 2007
CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profilePing Kang, Mingxiang Liao, Michael R Wester, et al.
Pageof 4